SCHEMBL2572299

SCHEMBL2572299

CC=CCCC=CCCC(C)=C(C)C(C)=O

nearest known ligand 0.36

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
PPARG P37231 2/20 0.36
PPARD Q03181 1/20 0.36
PPARA Q07869 1/20 0.36
ALDH1A1 P00352 2/20 0.32
MAPT P10636 2/20 0.32
FFAR1 O14842 1/20 0.32
CYP19A1 P11511 1/20 0.32
RXRA P19793 1/20 0.32
OXER1 Q8TDS5 1/20 0.32
F13A1 P00488 1/20 0.32
THRB P10828 1/20 0.32
PTGS1 P23219 1/20 0.32
FASN P49327 1/20 0.32
SMN1; SMN2 Q16637 1/20 0.32
TOP1 P11387 2/20 0.31
FNTA P49354 1/20 0.30
FNTB P49356 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5276835 0.85 FNTA (0.40) PPARGPPARDPPARAALDH1A1MAPT
SCHEMBL3406148 0.82
SCHEMBL3406145 0.82
SCHEMBL6035351 0.80 PPARG (0.33) PPARGPPARDPPARAALDH1A1
SCHEMBL11620351 0.80 FNTA (0.38) PPARGPPARDPPARAALDH1A1MAPT
SCHEMBL11620350 0.80 FNTA (0.38) PPARGPPARDPPARAALDH1A1MAPT
SCHEMBL16698266 0.77 ALDH1A1 (0.45) PPARGPPARDPPARAALDH1A1MAPT
SCHEMBL1650008 0.77 ALDH1A1 (0.45) PPARGPPARDPPARAALDH1A1MAPT
SCHEMBL672481 0.77 ALDH1A1 (0.45) PPARGPPARDPPARAALDH1A1MAPT
SCHEMBL1650009 0.77 ALDH1A1 (0.45) PPARGPPARDPPARAALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3468943-A1 PROCESS FOR THE PREPARATION OF ALCOHOLS FROM ALFA,BETA-UNSATURATED ALDEHYDES AND KETONES Givaudan SA (CH) 2019-04-17 EP disclosed
EP-3356356-A1 COMPOUNDS USEFUL AS MODULATORS OF TRPM8 Senomyx, Inc. (US) 2018-08-08 EP disclosed
WO-2017212069-A1 PROCESS FOR THE PREPARATION OF ALCOHOLS FROM ALFA,BETA-UNSATURATED ALDEHYDES AND KETONES GIVAUDAN SA (CH) 2017-12-14 WO disclosed
WO-2015128428-A1 PHEROMONE DISPENSER MADE OF PLASTIC MATERIAL BASF SE (DE) 2015-09-03 WO disclosed
EP-2384111-A1 PHEROMONE DISPENSER BASF SE (DE) 2011-11-09 EP disclosed
WO-2010076316-A1 PHEROMONE DISPENSER BASF SE (DE) 2010-07-08 WO disclosed
US-20090092642-A1 Skin and/or Hair Products, Containing Compounds With an Isoprenoid Structure BEIERSDORF AG (DE) 2009-04-09 US disclosed
EP-1755546-A2 SKIN AND/OR HAIR PRODUCTS, CONTAINING COMPOUNDS WITH AN ISOPRENOID STRUCTURE Beiersdorf AG (DE) 2007-02-28 EP disclosed
WO-2005102252-A2 SKIN AND/OR HAIR PRODUCTS, CONTAINING COMPOUNDS WITH AN ISOPRENOID STRUCTURE BEIERSDORF AG (DE) 2005-11-03 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090092642-A1 Skin and/or Hair Products, Containing Compounds With an Isoprenoid Structure SRD5A2, SRD5A1, CUTA PPARG 912/4885PPARD 1422/4885PPARA 1533/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.